Abstract:Objective To determine the role of hypoxia-inducible factor-1alpha(HIF-1α) on aerobic glycolysis and cell growth in SHG44 cells using siRNA silencing HIF-1α.Methods CoCl2 was used to mimic hypoxia;siRNA technique was used to silence HIF-1α in SHG44 cells.SHG44 cells were divided into 4 groups,including normal culture group,hypoxia culture group,negative control group and HIF-1α siRNA group.Each group was further divided into 2 subgroups,normal glucose intensity group(2 g/L) and high glucose intensity group(5 g/L).The expression of HIF-1α and glycolysis enzymes was measured by real-time PCR and Western blot analysis.Intracellular ATP levels were measured by bioluminescence assay.Cell viability was measured by MTT assay.Apoptotic and death cells and intracellular reactive oxygen species(ROS) were detected by flow cytometry.The alteration of transmembrane potential of mitochondria was determined by confocal laser scanning microscopy.Results Under hypoxia,the efficiency of siRNA silencing HIF-1α gene reached to 71%.The mRNA and protein levels of HIF-1α,PKM2,PDK1 and LDHA in the hypoxia culture group were significantly higher than those of normal culture group.Tumor cells showed higher proliferation rate and increased necrosis and apoptosis rate than the cells under normal culture.Moreover,tumor cells had lower intracellular ATP concentrations and elevated mitochondrial membrane potential(all P<0.05).The growth inhibition ratio of cells in HIF-1α siRNA group was significantly higher than that of other groups including hypoxia culture group and negative control group(all P<0.05).The levels of glycolytic enzymes PKM2,PDK1 and LDHA in HIF-1α siRNA group were significantly lower than those of hypoxia culture group and negative control group(P<0.05).Treatment with HIF-1α siRNA decreased the elevated mitochondrial membrane potential in cancer cells,which was also associated with a sharp decrease in intracellular ATP level.Conclusion Aerobic glycolysis of cancer cells may contribute directly to carcinogenic progression and malignant transformation by promoting the expression of HIF-1α-regulated genes under hypoxic conditions.HIF-1α gene silencing aggravates growth inhibition and necrosis of SHG44 cells under hypoxia.

Novel Hypoxia-slective Compound Q39 Induced Bel-7402 Cell Apoptosis via Blocking HIF-1 Translocation

Q39, a novel synthetic Quinoxaline 1,4-Di-N-oxide compound with anti-cancer activity in hypoxia.

Q39 induces apoptosis in human leukemia cell line K562 in hypoxia

Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1α expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells

Q39, A Quinoxaline 1,4-Di-N-Oxide Derivative, Inhibits Hypoxia-Inducible Factor-1 Alpha Expression And The Akt/Mtor/4e-Bp1 Signaling Pathway In Human Hepatoma Cells

Synthesis And Biological Evaluation Of 3-Aryl-Quinoxaline-2-Carbonitrile 1,4-Di-N-Oxide Derivatives As Hypoxic Selective Anti-Tumor Agents

Correlation of Pharmacokinetic Features and Tissue Distribution with Toxicity of Q39, a Hypoxic Cell Cytotoxic Agent.

Synthesis and Biological Evaluation of 3-Aryl-quinoxaline-2-carbonitrile 1,4-Di-<em>N</em>-oxide Derivatives as Hypoxic Selective Anti-tumor Agents

Synthesis and Cytotoxic Activity of 3-Phenyl-2-thio-quinoxaline 1,4-Dioxide Derivatives in Hypoxia and in Normoxia.

Effect of Hypoxia on Inducing Apoptosis in Non-small Cell Lung Cancer A549 and Expression of Survivin

Identification of novel 4-anilinoquinazoline derivatives as potent EGFR inhibitors both under normoxia and hypoxia.

XQ2, a Novel TPZ Derivative, Induced G2/M Phase Arrest and Apoptosis under Hypoxia in Non-Small Cell Lung Cancer Cells

Design, Synthesis and Biological Evaluation of 6-(Nitroimidazole-1h-alkyloxyl)-4-anilinoquinazolines As Efficient EGFR Inhibitors Exerting Cytotoxic Effects Both under Normoxia and Hypoxia.

Design, Synthesis, and Biological Study of 4-[(2-nitroimidazole-1h-alkyloxyl)aniline]-quinazolines As EGFR Inhibitors Exerting Cytotoxicities Both under Normoxia and Hypoxia.

[Anticancer Effect of SN-38 Combined with Sorafenib on Hepatocellular Carcinoma in Vitro and Its Mechanism].

Q6, a Novel Hypoxia-Targeted Drug, Regulates Hypoxia-Inducible Factor Signaling Via an Autophagy-Dependent Mechanism in Hepatocellular Carcinoma

A Novel Stilbene Derivative (GMQ3) Suppressed Proliferation and Induced Apoptosis in Lung Cancer Via the P38-Mapk/sirt1 Pathway

The Effect of Silencing HIF-1α Gene in BxPC-3 Cell Line on Glycolysis-Related Gene Expression, Cell Growth, Invasion, and Apoptosis

Hypoxia-selective cytotoxicity and radiosensitization of quinoxaline 1,4-di-N-oxide derivative, QN-2013

Reversal of glycolytic phenotype by HIF-1α siRNA inhibits SHG44 cell growth in vitro

Synthesis and evaluation of 3-(phenylethynyl)-1,1′-biphenyl-2-carboxylate derivatives as new HIF-1 inhibitors